|
☒
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
11-3027591
(IRS Employer Identification No.) |
|
445 Park Avenue, Suite 912
New York, New York
(Address of Principal Executive Offices)
|
10022
(Zip Code)
|
|
Title of each class
Common Stock, par value $0.01 per share
|
Trading symbol
NTIP |
Name of each exchange on which registered
NYSE American
|
|
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
|
|
|
|
|
Non-accelerated filer ☐
|
|
Smaller reporting company ☒
|
|
Emerging growth Company ☐
|
|
Page No.
|
|
|
PART I. Financial Information
|
|
|
Item 1. Condensed Consolidated Financial Statements (unaudited)
|
|
|
Condensed Consolidated Balance Sheets as of September 30, 2019 and December 31, 2018
|
3 |
|
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and nine months ended September 30, 2019 and 2018
|
4 |
|
Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2019 and 2018
|
5 |
|
|
|
|
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2019 and 2018
|
7 |
|
Notes to Unaudited Condensed Consolidated Financial Statements
|
8 |
|
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
|
31 |
|
Item 3. Quantitative and Qualitative Disclosures About Market Risk
|
38 |
|
Item 4. Controls and Procedures
|
38 |
|
PART II. Other Information
|
|
|
Item 1. Legal Proceedings
|
39 |
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
41 |
|
Item 3. Defaults Upon Senior Securities
|
42 |
|
Item 4. Other Information
|
42 |
|
Item 5. Exhibits
|
42 |
|
Signatures
|
43 |
| ASSETS: |
September 30,
2019
|
December 31,
2018
|
||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
16,737,000
|
$
|
23,763,000
|
||||
|
Marketable securities, at fair value
|
31,283,000
|
31,228,000
|
||||||
|
Royalty receivables, net
|
493,000
|
444,000
|
||||||
|
Other current assets
|
31,000
|
112,000
|
||||||
|
Total Current Assets
|
$
|
48,544,000
|
$
|
55,547,000
|
||||
|
OTHER ASSETS:
|
||||||||
|
Deferred tax assets
|
204,000
|
168,000
|
||||||
|
Patents, net of accumulated amortization
|
1,832,000
|
1,989,000
|
||||||
|
Equity investment
|
4,696,000
|
2,541,000
|
||||||
|
Operating leases right-of-use asset
|
52,000
|
—
|
||||||
|
Security deposits
|
21,000
|
21,000
|
||||||
|
Total Other Assets
|
6,805,000
|
4,719,000
|
||||||
|
TOTAL ASSETS
|
$
|
55,349,000
|
$
|
60,266,000
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY:
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Accounts payable
|
245,000
|
67,000
|
||||||
|
Income taxes payable
|
—
|
197,000
|
||||||
|
Accrued contingency fees and related costs
|
112,000
|
1,136,000
|
||||||
|
Accrued payroll
|
30,000
|
486,000
|
||||||
|
Operating lease obligations – current
|
53,000
|
—
|
||||||
|
Other accrued expenses
|
198,000
|
175,000
|
||||||
|
TOTAL CURRENT LIABILITIES
|
$
|
638,000
|
$
|
2,061,000
|
||||
|
TOTAL LIABILITIES
|
$
|
638,000
|
$
|
2,061,000
|
||||
|
COMMITMENTS AND CONTINGENCIES
|
||||||||
|
STOCKHOLDERS' EQUITY
|
||||||||
|
Preferred stock, $0.01 par value, authorized 10,000,000 shares;
|
||||||||
|
none issued and outstanding at September 30, 2019 and
|
||||||||
|
December 31, 2018
|
—
|
—
|
||||||
|
Common stock, $0.01 par value; authorized 50,000,000 shares;
|
||||||||
|
24,137,841 and 23,735,927 shares issued and outstanding at
|
||||||||
|
September 30, 2019 and December 31, 2018, respectively
|
241,000
|
237,000
|
||||||
|
Additional paid-in capital
|
65,678,000
|
65,151,000
|
||||||
|
Accumulated deficit
|
(11,310,000
|
) |
(7,102,000
|
) | ||||
|
Accumulated other comprehensive income (loss)
|
102,000
|
(81,000
|
)
|
|||||
|
TOTAL STOCKHOLDERS' EQUITY
|
54,711,000
|
58,205,000
|
||||||
|
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
55,349,000
|
$
|
60,266,000
|
||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
REVENUE
|
$
|
520,000
|
$
|
1,798,000
|
$
|
1,725,000
|
$
|
21,732,000
|
||||||||
|
OPERATING EXPENSES:
|
||||||||||||||||
|
Costs of revenue
|
138,000
|
596,000
|
459,000
|
7,988,000
|
||||||||||||
|
Professional fees and related costs
|
267,000
|
352,000
|
812,000
|
1,456,000
|
||||||||||||
|
General and administrative
|
466,000
|
491,000
|
1,442,000
|
1,460,000
|
||||||||||||
|
Amortization of patents
|
71,000
|
70,000
|
212,000
|
209,000
|
||||||||||||
|
Stock-based compensation
|
154,000
|
120,000
|
425,000
|
571,000
|
||||||||||||
|
TOTAL OPERATING EXPENSES
|
1,096,000
|
1,629,000
|
3,350,000
|
11,684,000
|
||||||||||||
|
OPERATING INCOME (LOSS)
|
(576,000
|
)
|
169,000
|
(1,625,000
|
)
|
10,048,000
|
||||||||||
|
OTHER INCOME (LOSS):
|
||||||||||||||||
|
Interest and dividend income, net
|
270,000
|
244,000
|
872,000
|
590,000
|
||||||||||||
|
Net realized and unrealized gain (loss) on marketable securities
|
(39,000
|
)
|
—
|
6,000
|
—
|
|||||||||||
|
Total other income, net
|
231,000
|
244,000
|
878,000
|
590,000
|
||||||||||||
|
INCOME (LOSS) BEFORE INCOME TAXES AND EQUITY IN NET LOSSES OF EQUITY METHOD INVESTEE
|
(345,000
|
)
|
413,000
|
(747,000
|
)
|
10,638,000
|
||||||||||
|
INCOME TAXES PROVISION (BENEFIT):
|
||||||||||||||||
|
Current
|
(197,000
|
)
|
167,000
|
(197,000
|
)
|
2,355,000
|
||||||||||
|
Deferred taxes, net
|
67,000
|
—
|
(36,000
|
)
|
—
|
|||||||||||
|
Total income taxes provision (benefit)
|
(130,000
|
)
|
167,000
|
(233,000
|
)
|
2,355,000
|
||||||||||
|
INCOME (LOSS) BEFORE SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE:
|
(215,000
|
)
|
$
|
246,000
|
(514,000
|
)
|
$
|
8,283,000
|
||||||||
|
SHARE OF NET (LOSSES) OF EQUITY METHOD INVESTEE
|
$
|
(196,000
|
)
|
$
|
—
|
$
|
(345,000
|
)
|
$
|
—
|
||||||
|
NET INCOME (LOSS)
|
$
|
(411,000
|
)
|
$
|
246,000
|
$
|
(859,000
|
)
|
$
|
8,283,000
|
||||||
|
Net Income (Loss) Per Share
|
||||||||||||||||
|
Basic
|
$
|
(0.02
|
)
|
$
|
0.01
|
$
|
(0.04
|
)
|
$
|
0.35
|
||||||
|
Diluted
|
$
|
(0.02
|
)
|
$
|
0.01
|
$
|
(0.04
|
)
|
$
|
0.33
|
||||||
|
Weighted average common shares outstanding:
|
||||||||||||||||
|
Basic
|
24,138,191
|
23,525,645
|
23,935,304
|
23,767,700
|
||||||||||||
|
Diluted
|
24,138,191
|
24,922,434
|
23,935,304
|
25,457,953
|
||||||||||||
|
Cash dividends declared per share
|
$
|
0.05
|
$
|
0.05
|
$
|
0.10
|
$
|
0.10
|
||||||||
|
NET INCOME (LOSS)
|
$
|
(411,000
|
)
|
$
|
246,000
|
$
|
(859,000
|
)
|
$
|
8,283,000
|
||||||
|
OTHER COMPREHENSIVE INCOME (LOSS)
|
||||||||||||||||
|
Net unrealized holding gain (loss) on corporate bonds and notes arising during the period, net of tax
|
20,000
|
(5,000
|
)
|
183,000
|
(39,000
|
)
|
||||||||||
|
COMPREHENSIVE INCOME (LOSS)
|
$
|
(391,000
|
)
|
$
|
241,000
|
$
|
(676,000
|
)
|
$
|
8,244,000
|
||||||
|
Common Stock
|
Additional
Paid-in Capital
|
Accumulated Deficit
|
Accumulated Other Comprehensive Income (Loss)
|
Total Stockholders' Equity
|
||||||||||||||||||||
|
Shares
|
Amount | |||||||||||||||||||||||
|
Balance – December 31, 2018
|
23,735,927
|
$
|
237,000
|
$
|
65,151,000
|
$
|
(7,102,000
|
)
|
$
|
(81,000
|
)
|
$
|
58,205,000
|
|||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(1,215,000
|
)
|
―
|
(1,215,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
144,000
|
―
|
―
|
144,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
11,250
|
―
|
―
|
―
|
―
|
―
|
||||||||||||||||||
|
Cashless exercise of stock options
|
105,000
|
1,000
|
(1,000
|
)
|
―
|
―
|
―
|
|||||||||||||||||
|
Shares delivered to fund stock option exercises
|
(69,116
|
)
|
―
|
―
|
―
|
―
|
―
|
|||||||||||||||||
|
Treasury stock purchased and retired
|
(300
|
)
|
―
|
―
|
(1,000
|
)
|
―
|
(1,000
|
)
|
|||||||||||||||
|
Net unrealized gain on corporate bonds and notes
|
―
|
―
|
―
|
―
|
110,000
|
110,000
|
||||||||||||||||||
|
Net loss
|
―
|
―
|
―
|
(240,000
|
)
|
―
|
(240,000
|
)
|
||||||||||||||||
|
Balance – March 31, 2019
|
23,782,761
|
$
|
238,000
|
$
|
65,294,000
|
$
|
(8,558,000
|
)
|
$
|
29,000
|
$
|
57,003,000
|
||||||||||||
|
Stock-based compensation
|
―
|
―
|
127,000
|
―
|
―
|
127,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
11,250
|
―
|
―
|
―
|
―
|
―
|
||||||||||||||||||
|
Proceeds from exercise of stock options
|
65,150
|
―
|
107,000
|
―
|
―
|
107,000
|
||||||||||||||||||
|
Cashless exercise of stock options
|
859,849
|
9,000
|
(9,000
|
)
|
―
|
―
|
―
|
|||||||||||||||||
|
Shares delivered to fund stock option exercises
|
(490,351
|
)
|
(5,000
|
)
|
5,000
|
―
|
―
|
―
|
||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
―
|
―
|
―
|
(366,000
|
)
|
―
|
(366,000
|
)
|
||||||||||||||||
|
Treasury stock purchased and retired
|
(139,848
|
)
|
(1,000
|
)
|
―
|
(332,000
|
)
|
―
|
(333,000
|
)
|
||||||||||||||
|
Net unrealized gain on corporate bonds and notes
|
―
|
―
|
―
|
―
|
53,000
|
53,000
|
||||||||||||||||||
|
Net loss
|
―
|
―
|
―
|
(208,000
|
)
|
―
|
(208,000
|
)
|
||||||||||||||||
|
Balance – June 30, 2019
|
24,088,811
|
$
|
241,000
|
$
|
65,524,000
|
$
|
(9,464,000
|
)
|
$
|
82,000
|
$
|
56,383,000
|
||||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(1,227,000
|
)
|
―
|
(1,227,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
154,000
|
―
|
154,000
|
|||||||||||||||||||
|
Vesting of restricted stock units
|
136,250
|
1,000
|
(1,000
|
)
|
―
|
―
|
―
|
|||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
(56,813
|
)
|
(1,000
|
)
|
1,000
|
(133,000
|
)
|
―
|
(133,000
|
)
|
||||||||||||||
|
Treasury stock purchased and retired
|
(30,407
|
)
|
―
|
―
|
(75,000
|
)
|
―
|
(75,000
|
)
|
|||||||||||||||
|
Net unrealized gain on corporate bonds and notes
|
―
|
―
|
―
|
―
|
20,000
|
20,000
|
||||||||||||||||||
|
Net loss
|
―
|
―
|
―
|
(411,000
|
)
|
―
|
(411,000
|
)
|
||||||||||||||||
|
Balance – September 30, 2019
|
24,137,841
|
$
|
241,000
|
$
|
65,678,000
|
$
|
(11,310,000
|
)
|
$
|
102,000
|
$
|
54,711,000
|
||||||||||||
|
Common Stock
|
Additional
Paid-in Capital
|
Accumulated Deficit
|
Accumulated Other Comprehensive Income (Loss)
|
Total Stockholders' Equity
|
||||||||||||||||||||
| Shares |
Amount
|
|||||||||||||||||||||||
|
Balance – December 31, 2017
|
23,843,915
|
$
|
238,000
|
$
|
64,435,000
|
$
|
(10,219,000
|
)
|
$
|
(42,000
|
)
|
$
|
54,412,000
|
|||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(1,228,000
|
)
|
―
|
(1,228,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
226,000
|
―
|
―
|
226,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
11,250
|
―
|
―
|
―
|
―
|
―
|
||||||||||||||||||
|
Cashless exercise of stock options
|
50,000
|
1,000
|
―
|
―
|
―
|
1,000
|
||||||||||||||||||
|
Shares delivered to fund stock option exercise
|
(23,110
|
)
|
―
|
―
|
―
|
―
|
―
|
|||||||||||||||||
|
Proceeds from exercise of stock options
|
25,000
|
1,000
|
29,000
|
―
|
―
|
30,000
|
||||||||||||||||||
|
Treasury stock purchased and retired
|
(153,993
|
)
|
(2,000
|
)
|
―
|
(397,000
|
)
|
―
|
(399,000
|
)
|
||||||||||||||
|
Net unrealized loss on corporate bonds and notes
|
―
|
―
|
―
|
―
|
(25,000
|
)
|
(25,000
|
)
|
||||||||||||||||
|
Net income
|
―
|
―
|
―
|
8,601,000
|
―
|
8,601,000
|
||||||||||||||||||
|
Balance – March 31, 2018
|
23,753,062
|
$
|
238,000
|
$
|
64,690,000
|
$
|
(3,243,000
|
)
|
$
|
(67,000
|
)
|
$
|
61,618,000
|
|||||||||||
|
Stock-based compensation
|
―
|
―
|
225,000
|
―
|
―
|
225,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
81,250
|
―
|
―
|
―
|
―
|
―
|
||||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
(16,784
|
)
|
―
|
2,000
|
(53,000
|
)
|
―
|
(51,000
|
)
|
|||||||||||||||
|
Cashless exercise of stock options
|
300,000
|
3,000
|
(3,000
|
)
|
―
|
―
|
―
|
|||||||||||||||||
|
Shares delivered to fund stock option exercises
|
(181,936
|
)
|
(2,000
|
)
|
2,000
|
―
|
―
|
―
|
||||||||||||||||
|
Treasury stock purchased and retired
|
(302,363
|
)
|
(3,000
|
)
|
―
|
(882,000
|
)
|
―
|
(885,000
|
)
|
||||||||||||||
|
Net unrealized loss on corporate bonds and notes
|
―
|
―
|
―
|
―
|
(9,000
|
)
|
(9,000
|
)
|
||||||||||||||||
|
Net loss
|
―
|
―
|
―
|
(564,000
|
)
|
―
|
(564,000
|
)
|
||||||||||||||||
|
Balance – June 30, 2018
|
23,633,229
|
$
|
236,000
|
$
|
64,916,000
|
$
|
(4,742,000
|
)
|
$
|
(76,000
|
)
|
$
|
60,334,000
|
|||||||||||
|
Dividends and dividend equivalents declared
|
―
|
―
|
―
|
(1,217,000
|
)
|
―
|
(1,217,000
|
)
|
||||||||||||||||
|
Stock-based compensation
|
―
|
―
|
120,000
|
―
|
―
|
120,000
|
||||||||||||||||||
|
Vesting of restricted stock units
|
386,250
|
3,000
|
(3,000
|
)
|
―
|
―
|
―
|
|||||||||||||||||
|
Value of shares delivered to pay withholding taxes
|
(172,313
|
)
|
(2,000
|
)
|
2,000
|
(490,000
|
)
|
―
|
(490,000
|
)
|
||||||||||||||
|
Treasury stock purchased and retired
|
(91,995
|
)
|
―
|
―
|
(249,000
|
)
|
―
|
(249,000
|
)
|
|||||||||||||||
|
Net unrealized loss on corporate bonds and notes
|
―
|
―
|
―
|
―
|
(5,000
|
)
|
(5,000
|
)
|
||||||||||||||||
|
Net income
|
―
|
―
|
―
|
246,000
|
―
|
246,000
|
||||||||||||||||||
|
Balance – September 30, 2018
|
23,755,171
|
$
|
237,000
|
$
|
65,035,000
|
$
|
(6,452,000
|
)
|
$
|
(81,000
|
)
|
$
|
58,739,000
|
|||||||||||
|
Nine Months Ended
September 30,
|
||||||||
| 2019 | 2018 | |||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income (loss)
|
$
|
(859,000
|
)
|
$
|
8,283,000
|
|||
|
Adjustments to reconcile net income(loss)to net cash
|
||||||||
|
(used in) provided by operating activities:
|
||||||||
|
Amortization of patents
|
212,000
|
209,000
|
||||||
|
Stock-based compensation
|
425,000
|
571,000
|
||||||
|
Loss from equity investment
|
345,000
|
―
|
||||||
|
Deferred tax benefit
|
(36,000
|
)
|
―
|
|||||
|
Amortization of right of use asset, net
|
76,000
|
―
|
||||||
|
Unrealized gain on marketable securities
|
(17,000
|
)
|
―
|
|||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Royalty receivables
|
(49,000
|
)
|
(1,286,000
|
)
|
||||
|
Prepaid taxes
|
―
|
125,000
|
||||||
|
Other current assets
|
81,000
|
65,000
|
||||||
|
Accounts payable
|
178,000
|
(85,000
|
)
|
|||||
|
Income taxes payable
|
(197,000
|
)
|
744,000
|
|||||
|
Operating lease obligations
|
(74,000
|
)
|
―
|
|||||
|
Accrued expenses
|
(1,473,000
|
)
|
(1,334,000
|
)
|
||||
|
NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES
|
(1,388,000
|
)
|
7,292,000
|
|||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Sales of marketable securities
|
30,836,000
|
―
|
||||||
|
Increase in security deposit
|
―
|
(2,000
|
)
|
|||||
|
Purchases of marketable securities
|
(30,691,000
|
)
|
(26,601,000
|
)
|
||||
|
Development of patents
|
(55,000
|
)
|
(102,000
|
)
|
||||
|
Equity Investment
|
(2,500,000
|
)
|
―
|
|||||
|
NET CASH USED IN INVESTING ACTIVITY
|
(2,410,000
|
)
|
(26,705,000
|
)
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Cash dividends paid
|
(2,428,000
|
)
|
(2,445,000
|
)
|
||||
|
Value of shares delivered to fund withholding taxes
|
(499,000
|
)
|
(545,000
|
)
|
||||
|
Repurchases of common stock, inclusive of commissions
|
(408,000
|
)
|
(1,535,000
|
)
|
||||
|
Proceeds from exercise of options
|
107,000
|
30,000
|
||||||
|
NET CASH USED IN FINANCING ACTIVITIES
|
(3,228,000
|
)
|
(4,495,000
|
)
|
||||
|
NET DECREASE IN CASH AND CASH EQUIVALENTS
|
(7,026,000
|
)
|
(23,908,000
|
)
|
||||
|
CASH AND CASH EQUIVALENTS, beginning of period
|
23,763,000
|
51,101,000
|
||||||
|
CASH AND CASH EQUIVALENTS, end of period
|
16,737,000
|
$
|
27,193,000
|
|||||
|
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$
|
―
|
$
|
―
|
||||
|
Income taxes
|
$
|
―
|
1,501,000
|
|||||
|
NON-CASH FINANCING ACTIVITY
|
||||||||
|
Accrued dividend rights on restricted stock units
|
$
|
50,000
|
$
|
61,000
|
||||
|
[1]
|
Use of Estimates and Assumptions
|
|
[2]
|
Cash and Cash Equivalents
|
|
[3]
|
Marketable Securities
|
|
[4]
|
Revenue Recognition
|
| ● |
identification of the license agreement;
|
| ● |
identification of the performance obligations in the license agreement;
|
| ● |
determination of the consideration for the license;
|
| ● |
allocation of the transaction price to the performance obligations in the contract; and
|
| ● |
recognition of revenue when the Company satisfies its performance obligations.
|
|
Three Months
Ended September 30, |
Nine Months
Ended September 30, |
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
Fully-Paid – Licenses
|
$
|
―
|
$
|
1,000,000 |
$
|
130,000
|
(1)
|
$
|
13,700,000
|
|||||||
|
Royalty Bearing - Licenses
|
520,000
|
798,000
|
1,595,000
|
1,712,000
|
||||||||||||
|
Other Revenue
|
―
|
―
|
―
|
6,320,000
|
(2)
|
|||||||||||
|
Total Revenue
|
$
|
520,000
|
$
|
1,798,000
|
$
|
1,725,000
|
$
|
21,732,000
|
||||||||
|
[5]
|
Equity Method Investments
|
|
[6]
|
Patents
|
|
[7]
|
Costs of Revenue
|
|
[8]
|
Income Taxes
|
|
[9]
|
Stock-Based Compensation
|
|
[10]
|
Earnings Per Share
|
|
[11]
|
Fair Value Measurements
|
|
[12]
|
Carrying Value, Recoverability and Impairment of Long-Lived Assets
|
|
[13]
|
Dividend Policy
|
|
[14]
|
Reclassification
|
|
[15]
|
New Accounting Standards
|
|
September 30, 2019
|
December 31, 2018
|
|||||||
|
Gross carrying amount – patents
|
$
|
7,737,000
|
$
|
7,682,000
|
||||
|
Accumulated amortization – patents
|
(5,905,000
|
)
|
(5,693,000
|
)
|
||||
|
Patents, net
|
$
|
1,832,000
|
$
|
1,989,000
|
||||
| Twelve Months Ended September 30, | ||||
|
2020
|
$
|
285,000
|
||
|
2021
|
285,000
|
|||
|
2022
|
285,000
|
|||
|
2023
|
240,000
|
|||
|
2024 and thereafter
|
737,000
|
|||
|
Total
|
$
|
1,832,000
|
||
|
Number of Shares
|
Weighted-Average Grant Date Fair Value
|
|||||||
|
Balance of restricted stock units outstanding at December 31, 2018
|
505,000 |
$
|
2.17
|
|||||
|
Grants of restricted stock units
|
45,000
|
2.60
|
||||||
|
Vested restricted stock units
|
(158,750
|
)
|
2.16
|
|||||
|
Balance of unvested restricted stock units at September 30, 2019
|
391,250 |
$
|
2.23
|
|||||
|
Range of
Exercise Price |
Options
Outstanding |
Weighted Average Exercise
Price |
Weighted
Average Remaining Life in Years |
Options
Exercisable |
||||
|
$1.19 - $2.34
|
605,000
|
$1.39
|
2.61
|
605,000
|
|
Nine Months Ended
September 30, |
Three Months Ended
September 30, |
|||||||||||||||
|
2019
|
2018
|
2019
|
2018
|
|||||||||||||
|
Weighted-average common shares outstanding – basic
|
23,935,304
|
23,767,700
|
24,138,191
|
23,525,645
|
||||||||||||
|
Dilutive effect of options, warrants and restricted stock units
|
―
|
1,690,253
|
―
|
1,396,789
|
||||||||||||
|
Weighted-average common shares outstanding – diluted
|
23,935,304
|
25,457,953
|
24,138,191
|
24,922,434
|
||||||||||||
|
Options and restricted stock units excluded from the computation of diluted income (loss) per share because the effect of inclusion would have been anti-dilutive
|
996,250
|
―
|
996,250
|
―
|
||||||||||||
|
September 30, 2019
|
||||||||||||||||
|
Cost
Basis
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
|||||||||||||
|
Certificates of deposit
|
$
|
4,500,000
|
$
|
8,000
|
$
|
―
|
$
|
4,508,000
|
||||||||
|
Fixed income mutual funds
|
15,810,000
|
9,000
|
―
|
15,819,000
|
||||||||||||
|
Corporate bonds and notes
|
10,854,000
|
176,000
|
(74,000
|
)
|
10,956,000
|
|||||||||||
|
Total marketable securities
|
$
|
31,164,000
|
$
|
193,000
|
$
|
(74,000
|
)
|
$
|
31,283,000
|
|||||||
|
December 31, 2018
|
||||||||||||||||
|
Cost
Basis
|
Gross Unrealized Gains
|
Gross Unrealized Losses
|
Fair Value
|
|||||||||||||
|
Certificates of deposit
|
$
|
13,151,000
|
$
|
―
|
$
|
―
|
$
|
13,151,000
|
||||||||
|
Fixed income mutual funds
|
9,648,000
|
―
|
(8,000
|
)
|
9,640,000
|
|||||||||||
|
Corporate bonds and notes
|
8,518,000
|
―
|
(81,000
|
)
|
8,437,000
|
|||||||||||
|
Total marketable securities
|
$
|
31,317,000
|
―
|
$
|
(89,000
|
)
|
$
|
31,228,000
|
||||||||
|
Three Months Ended September 30, 2019
|
Nine Months Ended September 30, 2019
|
|||||||
|
Operating lease expense
|
$
|
33,000
|
$
|
107,000
|
||||
|
Cash paid for amounts included in the measurement of operating lease obligations
|
$
|
34,000
|
$
|
101,000
|
||||
|
As of
|
||||
|
September 30, 2019
|
||||
|
Operating lease right-of-use assets
|
$
|
52,000
|
||
|
Operating lease obligations – current
|
$
|
53,000
|
||
|
Total lease obligations
|
$
|
53,000
|
||
|
Weighted average remaining lease term (in months)
|
6 months
|
|||
|
Weighted average discount rate
|
5.5%
|
|
||
|
Operating Leases
|
||||
|
2019 – remaining period
|
$
|
34,000
|
||
|
2020
|
$
|
19,000
|
||
|
Total future minimum lease payments
|
$
|
53,000
|
||
|
Less imputed interest
|
(1,000
|
)
|
||
|
Total operating lease liability
|
$
|
52,000
|
||
|
Period
|
Total Number of Shares Purchased
|
Average Price Paid Per Share
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs
|
|
July 1 to July 31, 2019
|
—
|
—
|
—
|
$4,878,350
|
|
August 1 to August 31, 2019
|
15,607
|
$2.52
|
15,607
|
$4,838,992
|
|
September 1 to September 30, 2019
|
14,800
|
$2.38
|
14,800
|
$4,803,723
|
|
Total
|
30,407
|
$2.45
|
30,407
|
| 101 |
Interactive data files:**
|
| 101.INS |
XBRL Instance Document
|
| 101.SCH |
XBRL Scheme Document
|
| 101.CAL |
XBRL Calculation Linkbase Document
|
| 101.DEF |
XBRL Definition Linkbase Document
|
| 101.LAB |
XBRL Label Linkbase Document
|
| 101.PRE |
XBRL Presentation Linkbase Document
|
|
NETWORK-1 TECHNOLOGIES, INC.
|
|||
|
Date: November 14, 2019
|
By:
|
/s/ Corey M. Horowitz | |
|
Corey M. Horowitz
|
|||
|
Chairman and Chief Executive Officer
|
|||
|
Date: November 14, 2019
|
By:
|
/s/ David C. Kahn | |
|
David C. Kahn
|
|||
|
Chief Financial Officer
|
|||